These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 8745142
21. Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA. Provenzano AP, Besner GE, James PF, Harding PA. Growth Factors; 2005 Mar; 23(1):19-31. PubMed ID: 16019424 [Abstract] [Full Text] [Related]
22. Postnatally elevated levels of insulin-like growth factor (IGF)-II fail to rescue the dwarfism of IGF-I-deficient mice except kidney weight. Moerth C, Schneider MR, Renner-Mueller I, Blutke A, Elmlinger MW, Erben RG, Camacho-Hübner C, Hoeflich A, Wolf E. Endocrinology; 2007 Jan; 148(1):441-51. PubMed ID: 17008389 [Abstract] [Full Text] [Related]
23. Actions and interactions of growth hormone and insulin-like growth factor-II: body and organ growth of transgenic mice. Blackburn A, Schmitt A, Schmidt P, Wanke R, Hermanns W, Brem G, Wolf E. Transgenic Res; 1997 May; 6(3):213-22. PubMed ID: 9167269 [Abstract] [Full Text] [Related]
24. Parental imprinting of an Igf-2 transgene. Lee JE, Tantravahi U, Boyle AL, Efstratiadis A. Mol Reprod Dev; 1993 Aug; 35(4):382-90. PubMed ID: 8398116 [Abstract] [Full Text] [Related]
29. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Schirmacher P, Held WA, Yang D, Chisari FV, Rustum Y, Rogler CE. Cancer Res; 1992 May 01; 52(9):2549-56. PubMed ID: 1568224 [Abstract] [Full Text] [Related]
31. Increased and persistent circulating insulin-like growth factor II in neonatal transgenic mice suppresses developmental apoptosis in the pancreatic islets. Hill DJ, Strutt B, Arany E, Zaina S, Coukell S, Graham CF. Endocrinology; 2000 Mar 01; 141(3):1151-7. PubMed ID: 10698192 [Abstract] [Full Text] [Related]
36. Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. van Buul-Offers SC, de Haan K, Reijnen-Gresnigt MG, Meinsma D, Jansen M, Oei SL, Bonte EJ, Sussenbach JS, Van den Brande JL. J Endocrinol; 1995 Mar 01; 144(3):491-502. PubMed ID: 7537791 [Abstract] [Full Text] [Related]
37. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, Brinster RL, Palmiter RD. Endocrinology; 1988 Dec 01; 123(6):2827-33. PubMed ID: 3197646 [Abstract] [Full Text] [Related]
38. Local reduction of organ size in transgenic mice expressing a soluble insulin-like growth factor II/mannose-6-phosphate receptor. Zaina S, Newton RV, Paul MR, Graham CF. Endocrinology; 1998 Sep 01; 139(9):3886-95. PubMed ID: 9724044 [Abstract] [Full Text] [Related]